Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Rohit Mehra"'
Autor:
Richard L. Cantley, Xiaoming Wang, Zachery R. Reichert, Arul M. Chinnaiyan, Rahul Mannan, Xuhong Cao, Daniel E. Spratt, Ulka N. Vaishampayan, Joshi J. Alumkal, Todd M. Morgan, Ganesh Palapattu, Matthew S. Davenport, Liron Pantanowitz, Rohit Mehra
Publikováno v:
Cancer Cytopathology. 131:117-135
The diagnosis of metastatic prostatic cancer (MPC) by fine needle aspiration (FNA) can usually be rendered by typical cytomorphologic and immunohistochemical (IHC) features. However, MPC diagnosis may be complicated by transformation to atypical phen
Autor:
Alexander Zaslavsky, Andi K. Cani, Chia Jen Liu, Simpa S. Salami, Judith Stangl-Kremser, Randy Vince, Rohit Mehra, Razeen Karim, Ganesh S. Palapattu, Todd M. Morgan, Trinh Pham, Christopher M. Russell, Srinivas Nallandhighal, Aaron M. Udager, Kevin Hu, Marcin Cieslik, Skylar Groves
Publikováno v:
European Urology Oncology. 5:92-99
Background There is an ongoing need to develop prognostic biomarkers to improve the management of clear cell renal cell carcinoma (ccRCC). Objective To leverage enriched pathways in ccRCC to improve risk-stratification. Design, setting, and participa
Autor:
Allison May, Claire Williams, Stephanie The, Sean Kim, Nathan Schurman, Greg Shelley, Tyler Robinson, Simpa Salami, Rohit Mehra, Aaron Udager, Evan Keller
Publikováno v:
Cancer Research. 83:4700-4700
Background: Sarcomatoid renal cell carcinoma (sRCC) is thought to arise by epithelial to mesenchymal transition (EMT) of the parental tumor in diverse RCC including clear cell RCC (ccRCC). sRCC is also known to be highly immunogenic and also express
Autor:
E. Jaworski, Zachery R. Reichert, Gavin P. Jones, David G. Wallington, Todd M. Morgan, David Elliott, Brandon A. Mahal, Joshi J. Alumkal, Felix Y. Feng, S. Birer, Matthew J. Schipper, Edward M. Schaeffer, William C. Jackson, Amar U. Kishan, Rohit Mehra, Paul L. Nguyen, Matthew R. McFarlane, Karim Fizazi, L.A. Gharzai, Daniel E. Spratt, Howard M. Sandler, Susan Halabi, Robert T. Dess, Ralph Jiang, Neil K. Jairath
Publikováno v:
The Lancet Oncology. 22:402-410
Summary Background The international Intermediate Clinical Endpoints in Cancer of the Prostate working group has established metastasis-free survival as a surrogate for overall survival in localised prostate cancer based on the findings of 19 predomi
Autor:
Xiaoming Wang, Rahul Mannan, Yupin Zhang, Margaret Hogan, Dana King, Anya Chinnaiyan, Arul Chinnaiyan, Saravana Dhanasekaran, Rohit Mehra
Publikováno v:
Journal of Clinical Oncology. 41:707-707
707 Background: Birt-Hogg-Dubé (BHD) syndrome is associated with an increased risk of renal tumors including the hybrid oncocytic tumors (HOT), renal oncocytoma (RO) and chromophobe renal cell carcinoma (CHRCC). HOT are known to exhibit morphologica
Autor:
Udit Singhal, Stephanie Daignault-Newton, Rodney Dunn, Daniel Eidelberg Spratt, Linda Okoth, Felix Y Feng, Anna Johnson, Brian R Lane, Susan Linsell, Ghani Khurshid, Rohit Mehra, Elai Davicioni, Thomas Maatman, Frank Burks, Paul Rodriguez, Eduardo Kleer, Richard Sarle, David Christopher Miller, Michael L. Cher, Todd Matthew Morgan
Publikováno v:
Journal of Clinical Oncology. 41:345-345
345 Background: Decipher is a tissue-based genomic classifier (GC) developed and validated in the post-radical prostatectomy (RP) setting to help guide adjuvant treatment decisions for prostate cancer (PCa). We conducted the first prospective, random
Autor:
Yize Li, Tung-Shing M. Lih, Saravana M. Dhanasekaran, Rahul Mannan, Lijun Chen, Marcin Cieslik, Yige Wu, Rita Jiu-Hsien Lu, David J. Clark, Iga Kołodziejczak, Runyu Hong, Siqi Chen, Yanyan Zhao, Seema Chugh, Wagma Caravan, Nataly Naser Al Deen, Noshad Hosseini, Chelsea J. Newton, Karsten Krug, Yuanwei Xu, Kyung-Cho Cho, Yingwei Hu, Yuping Zhang, Chandan Kumar-Sinha, Weiping Ma, Anna Calinawan, Matthew A. Wyczalkowski, Michael C. Wendl, Yuefan Wang, Shenghao Guo, Cissy Zhang, Anne Le, Aniket Dagar, Alex Hopkins, Hanbyul Cho, Felipe da Veiga Leprevost, Xiaojun Jing, Guo Ci Teo, Wenke Liu, Melissa A. Reimers, Russell Pachynski, Alexander J. Lazar, Arul M. Chinnaiyan, Brian A. Van Tine, Bing Zhang, Karin D. Rodland, Gad Getz, D.R. Mani, Pei Wang, Feng Chen, Galen Hostetter, Mathangi Thiagarajan, W. Marston Linehan, David Fenyö, Scott D. Jewell, Gilbert S. Omenn, Rohit Mehra, Maciej Wiznerowicz, Ana I. Robles, Mehdi Mesri, Tara Hiltke, Eunkyung An, Henry Rodriguez, Daniel W. Chan, Christopher J. Ricketts, Alexey I. Nesvizhskii, Hui Zhang, Li Ding, Alicia Francis, Amanda G. Paulovich, Andrzej Antczak, Anthony Green, Antonio Colaprico, Ari Hakimi, Barb Pruetz, Barbara Hindenach, Birendra Kumar Yadav, Boris Reva, Brenda Fevrier-Sullivan, Brian J. Druker, Cezary Szczylik, Charles A. Goldthwaite, Chet Birger, Corbin D. Jones, Daniel C. Rohrer, Darlene Tansil, David Chesla, David Heiman, Elizabeth Duffy, Eri E. Schadt, Francesca Petralia, Gabriel Bromiński, Gabriela M. Quiroga-Garza, George D. Wilson, Ginny Xiaohe Li, Grace Zhao, Yi Hsiao, James Hsieh, Jan Lubiński, Jasmin Bavarva, Jasmine Huang, Jason Hafron, Jennifer Eschbacher, Jennifer Hon, Jesse Francis, John Freymann, Josh Vo, Joshua Wang, Justin Kirby, Kakhaber Zaalishvili, Karen A. Ketchum, Katherine A. Hoadley, Ki Sung Um, Liqun Qi, Marcin J. Domagalski, Matt Tobin, Maureen Dyer, Meenakshi Anurag, Melissa Borucki, Michael A. Gillette, Michael J. Birrer, Michael M. Ittmann, Michael H. Roehrl, Michael Schnaubelt, Michael Smith, Mina Fam, Nancy Roche, Negin Vatanian, Nicollette Maunganidze, Olga Potapova, Oxana V. Paklina, Pamela VanderKolk, Patricia Castro, Paweł Kurzawa, Pushpa Hariharan, Qin Li, Qing Kay Li, Rajiv Dhir, Ratna R. Thangudu, Rebecca Montgomery, Richard D. Smith, Sailaja Mareedu, Samuel H. Payne, Sandra Cerda, Sandra Cottingham, Sarah Haynes, Shankha Satpathy, Shannon Richey, Shilpi Singh, Shirley X. Tsang, Shuang Cai, Song Cao, Stacey Gabriel, Steven A. Carr, Tao Liu, Thomas Bauer, Toan Le, Xi S. Chen, Xu Zhang, Yvonne Shutack, Zhen Zhang
Publikováno v:
Cancer Cell. 41:139-163.e17
Clear cell renal cell carcinomas (ccRCCs) represent ∼75% of RCC cases and account for most RCC-associated deaths. Inter- and intratumoral heterogeneity (ITH) results in varying prognosis and treatment outcomes. To obtain the most comprehensive prof
Autor:
Chandan Kumar-Sinha, Yi-Mi Wu, Dan R. Robinson, Joshi J. Alumkal, Frank C. Cackowski, Arul M. Chinnaiyan, Rohit Mehra
Publikováno v:
JCO Precision Oncology
Autor:
Yang Liu, Elai Davicioni, Robert T. Dess, Simpa S. Salami, Peter R. Carroll, Tarek A. Bismar, Edward M. Schaeffer, Eric A. Klein, William C. Jackson, John W. Davis, Felix Y. Feng, Nick Fishbane, Anthony C. Wong, R. Jeffrey Karnes, Melody J. Xu, Brandon A. Mahal, Jeffrey J. Tosoian, Daniel E. Spratt, Rohit Mehra, Hyung L. Kim, Matthew R. Cooperberg, Colleen A. Lawton, Todd M. Morgan, Ashley E. Ross, William A. Hall, Robert B. Den, Paul Nguyen
Publikováno v:
JCO Precision Oncology. :1228-1238
PURPOSE Pretreatment estimates of seminal vesicle invasion (SVI) are challenging and significantly influence the management of prostate cancer. We sought to improve current models to predict SVI through the development of an SVI prediction genomic si
Autor:
S. Laura Chang, Jonathan Chou, Edward M. Schaeffer, Shuang G. Zhao, Kari Wilder-Romans, Karen E. Knudsen, David A. Quigley, Housheng Hansen He, Emanuela Dylgjeri, Scott A. Tomlins, Kristina Gabbara, Corey Speers, Dana E. Rathkopf, Jonathan F. Goodwin, Vishal Kothari, Ellen Filvaroff, Justin M. Drake, Yi Yin, Luke A. Gilbert, Arul M. Chinnaiyan, Felix Y. Feng, Alan Ashworth, Kristen Hege, Joseph R. Evans, R. Jeffrey Karnes, Rohit Mehra, Ganesh V. Raj, Daniel E. Spratt, G. Sun
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 18
Purpose: Protein kinases are known to play a prominent role in oncogenic progression across multiple cancer subtypes, yet their role in prostate cancer progression remains underexplored. The purpose of this study was to identify kinases that drive pr